Elucidating excited state electronic structure and intercomponent interactions in multicomponent and supramolecular systems

Rational design of supramolecular systems for application in photonic devices requires a clear understanding of both the mechanism of energy and electron transfer processes and how these processes can be manipulated. Central to achieving these goals is a detailed picture of their electronic structure and of the interaction between the constituent components. We review several approaches that have been taken towards gaining such understanding, with particular focus on the physical techniques employed. In the discussion, case studies are introduced to illustrate the key issues under consideration

Korrelasies tussen gesondheidstoestand van steendruiwe, chemiese samestelling van die mos en organoleptiese beoordeling van die wyn

Thesis (MScAgric)--Stellenbosch University, 1966.ENGLISH ABSTRACT: no abstract availableAFRIKAANSE OPSOMMING: geen opsommin

Ground vs. excited state interaction in ruthenium-thienyl dyads:implications for through bond interactions in multicomponent systems

The vibrational and photophysical properties of mononuclear ruthenium(II) and ruthenium(III) polypyridyl complexes based on the ligands 2-(5'-(pyridin-2"-yl)-1'H-1',2',4'-triaz-3'-yl)-thiophene, 2-(5'-(pyrazin-2"-yl)-1'H-1',2',4'-triaz-3'-yl)-thiophene, are reported. The effect of the introduction of the non-innocent thiophene group on the properties of the triazole based ruthenium(II) complex is examined. The pH sensitive 1,2,4-triazole group, although influenced by the electron withdrawing nature of the thiophene group, does not facilitate excited state interaction of the thiophene and Ru(II) centre. Deuteriation and DFT calculations are employed to enable a deeper understanding of the interaction between the two redox-active centres and rationalise the difference between the extent of ground and excited state interaction in this simple dyad. The results obtained provide considerable evidence in support of earlier studies examining differences in ground and excited state interaction in multinuclear thiophene-bridged systems, in particular with respect to HOMO- and LUMO- mediated superexchange interaction processes.

Synthesis, spectroscopy and photophysical properties of ruthenium triazole complexes and their application as dye-molecules in regenerative solar cells

The complexes [Ru(dcb)2(L)] (L = 3-(2-phenol)-5-(pyridin-2-yl)-1,2,4-triazole (2-ppt), 3-(4-phenol)-5-(pyridin-2-yl)-1,2,4-triazole (4-ppt), 3,5-bis(pyrazin-2-yl)-1,2,4-triazole (bpzt), 3-(2-phenol)-5-(pyrazin-2-yl)-1,2,4-triazole (2-ppzt) and dcb = 4,4’-(CO2H)2-2,2’-bipyridine) have been synthesized, spectroscopically characterized and anchored to nanocrystalline TiO2 electrodes for the conversion of light into electricity in regenerative solar cells. The different efficiencies observed have been rationalized on the basis of an analytical expression relating the incident photon-to-current-conversion efficiency (IPCE) to the kinetic parameters of the relevant electron transfer processes involved in the solar cell

Environmental determinants of fruit and vegetable consumption among adults: a systematic review.

The current ecological approach in health behaviour research recognises that health behaviour needs to be understood in a broad environmental context. This has led to an exponential increase in the number of studies on this topic. It is the aim of this systematic review to summarise the existing empirical evidence pertaining to environmental influences on fruit and vegetable (FV) consumption. The environment was defined as 'all factors external to the individual'. Scientific databases and reference lists of selected papers were systematically searched for observational studies among adults (18-60 years old), published in English between 1 January 1980 and 31 December 2004, with environmental factor(s) as independent factor(s), and fruit intake, vegetable intake or FV intake combined as one outcome measure as dependent factor(s). Findings showed there was a great diversity in the environmental factors studied, but that the number of replicated studies for each determinant was limited. Most evidence was found for household income, as people with lower household incomes consistently had a lower FV consumption. Married people had higher intakes than those who were single, whereas having children showed mixed results. Good local availability (e.g. access to one's own vegetable garden, having low food insecurity) seemed to exert a positive influence on intake. Regarding the development of interventions, improved opportunities for sufficient FV consumption among low-income households are likely to lead to improved intakes. For all other environmental factors, more replicated studies are required to examine their influence on FV intake

Long-term outcomes from the Phase II L-MIND study of tafasitamab (MOR208) plus lenalidomide in patients with relapsed or refractory diffuse large B-cell lymphoma

Tafasitamab; B-cell lymphomaTafasitamab; Linfoma de células BTafasitamab; Limfoma de cèl·lules BTafasitamab (MOR208), an Fc-modified, humanized, anti-CD19 monoclonal antibody, combined with the immunomodulatory drug lenalidomide was clinically active with a good tolerability profile in the open-label, single-arm, phase II L-MIND study of patients with relapsed/refractory diffuse large B-cell lymphoma (DLBCL) ineligible for autologous stem-cell transplantation. To assess long-term outcomes, we report an updated analysis with ≥35 months’ follow-up. Patients were aged >18 years, had received one to three prior systemic therapies (including ≥1 CD20-targeting regimen) and Eastern Cooperative Oncology Group performance status 0-2. Patients received 28-day cycles of tafasitamab (12 mg/kg intravenously), once weekly during cycles 1-3, then every 2 weeks during cycles 4-12. Lenalidomide (25 mg orally) was administered on days 1-21 of cycles 1-12. After cycle 12, progression-free patients received tafasitamab every 2 weeks until disease progression. The primary endpoint was best objective response rate. After ≥35 months’ follow-up (data cut-off: October 30, 2020), the objective response rate was 57.5% (n=46/80), including a complete response in 40.0% of patients (n=32/80) and a partial response in 17.5% of patients (n=14/80). The median duration of response was 43.9 months (95% confidence interval [95% CI]: 26.1-not reached), the median overall survival was 33.5 months (95% CI: 18.3-not reached) and the median progression-free survival was 11.6 months (95% CI: 6.3-45.7). There were no unexpected toxicities. Subgroup analyses revealed consistent long-term efficacy results across most subgroups of patients. This extended follow-up of L-MIND confirms the long duration of response, meaningful overall survival, and well-defined safety profile of tafasitamab plus lenalidomide followed by tafasitamab monotherapy in patients with relapsed/refractory diffuse large B-cell lymphoma ineligible for autologous stem cell transplantation. ClinicalTrials.gov identifier: NCT02399085

Effectiveness of progressive tendon-loading exercise therapy in patients with patellar tendinopathy:a randomised clinical trial

Objective To compare the effectiveness of progressive tendon-loading exercises (PTLE) with eccentric exercise therapy (EET) in patients with patellar tendinopathy (PT). Methods In a stratified, investigator-blinded, block-randomised trial, 76 patients with clinically diagnosed and ultrasound-confirmed PT were randomly assigned in a 1:1 ratio to receive either PTLE or EET. The primary end point was clinical outcome after 24 weeks following an intention-to-treat analysis, as assessed with the validated Victorian Institute of Sports Assessment for patellar tendons (VISA-P) questionnaire measuring pain, function and ability to play sports. Secondary outcomes included the return to sports rate, subjective patient satisfaction and exercise adherence. Results Patients were randomised between January 2017 and July 2019. The intention-to-treat population (mean age, 24 years, SD 4); 58 (76%) male) consisted of patients with mostly chronic PT (median symptom duration 2 years). Most patients (82%) underwent prior treatment for PT but failed to recover fully. 38 patients were randomised to the PTLE group and 38 patients to the EET group. The improvement in VISA-P score was significantly better for PTLE than for EET after 24 weeks (28 vs 18 points, adjusted mean between-group difference, 9 (95% CI 1 to 16); p=0.023). There was a trend towards a higher return to sports rate in the PTLE group (43% vs 27%, p=0.13). No significant between-group difference was found for subjective patient satisfaction (81% vs 83%, p=0.54) and exercise adherence between the PTLE group and EET group after 24 weeks (40% vs 49%, p=0.33). Conclusions In patients with PT, PTLE resulted in a significantly better clinical outcome after 24 weeks than EET. PTLE are superior to EET and are therefore recommended as initial conservative treatment for PT

Predicting success of vagus nerve stimulation (VNS) from interictal EEG

AbstractPurposeVagus nerve stimulation (VNS) has shown to be an effective treatment for drug resistant epilepsy in numerous patients, however, not in all. It is still not possible to predict which patients will profit from VNS. In this pilot study, we explore predictive interictal EEG features for seizure reduction after VNS.Methods19 Patients with medically refractory epilepsy and an implanted VNS system were included. Interictal EEG registrations, recorded before implantation, were retrospectively analysed. A quantative symmetry measure, the pair wise derived brain symmetry index (pdBSI), was tested to predict VNS outcome. Reduction in seizure frequency was used to define the responders.Results10 Patients did respond to VNS, of whom 7 patients had a seizure reduction of at least 50% in a follow-up period of 2 years. On average, we find higher pdBSI values for delta, theta, alpha and beta bands for non-responders than for responders. The average pdBSI of the theta and alpha bands could significantly discriminate between responders and non-responders.ConclusionIn this study, quantifying EEG symmetry using the pdBSI shows promising results in predicting the reduction of seizure frequency after VNS treatment

Structural and photophysical characterisation of coordination and optical isomers of mononuclear ruthenium(II) polypyridyl 1,2,4-triazole complexes

The X-ray crystal structure of the N2 isomers of the Ru(bipy)2 complexes of Hphpztr (1) and Hpztr (2), (bipy = 2,2'-bipyridine, Hphpztr = 2-(5'-phenyl-4'H-[1,2,4]triazol-3'-yl)pyrazine and Hpztr = 2-(4'H-[1,2,4]triazol-3'-yl)pyrazine) are reported. The molecular structure obtained for 2 demonstrates an interesting structural aspect in the sharing of a single proton between two molecular units. The isolation of the Δ and Λ stereoisomers of 1 and [Ru(phen)2(pztr)]+ (phen = 1,10-phenanthroline) (3) by semipreparative HPLC is also reported. The compounds obtained are characterised by electronic spectroscopy and particular attention is paid to the photophysical properties of Δ and Λ isomers of 1 and 3, in chiral enantiopure and racemic solvents